Trevor James
The hepatitis B vaccine was first developed in the 1980s and licensed in 1981. Initially, it was only recommended for high-risk groups, including infants born to hepatitis B-positive mothers, who were advised to receive the first dose within 12-24 hours of birth. However, in 1991, the recommendation was extended to include all infants and young children, leading to a significant decline in hepatitis B infections in the US. Today, the World Health Organization (WHO) and health experts universally recommend the hepatitis B vaccine for all newborns, and it is typically given as a three-dose series. While the timing may vary, the recommended schedule in the US is at birth, 1 month, and 6 months.
| Characteristics | Values |
|---|---|
| Year the Hepatitis B vaccine was first licensed | 1981 |
| Year the Hepatitis B vaccine was added to the recommended schedule for high-risk groups | 1981 |
| Year the Hepatitis B vaccine was added to the recommended schedule for all infants and young children | 1991 |
| Year Hepatitis B disease was virtually eliminated in children under 18 years of age in the US | By 1994 |
| Year Hepatitis B disease was virtually eliminated in children under 19 years of age in the US | By 2025 |
| Recommended age for first dose of Hepatitis B vaccine for infants born to mothers without Hepatitis B | Within 12-24 hours of birth |
| Recommended age for first dose of Hepatitis B vaccine for infants born to mothers with Hepatitis B | Within 12 hours of birth |
| Recommended age for first dose of Hepatitis B vaccine for infants weighing less than 2000 grams at birth | 1 month |
| Number of doses of Hepatitis B vaccine recommended for infants | 3 |
| Number of doses of Hepatitis B vaccine that may be required for infants weighing less than 2000 grams at birth | 4 |
| Recommended age for second dose of Hepatitis B vaccine | 1 month |
| Recommended age for third dose of Hepatitis B vaccine | 6 months |
| Organization that recommends Hepatitis B vaccine for all infants | World Health Organization (WHO) |
| Estimated percentage of infants worldwide who receive three doses of the Hepatitis B vaccine | Over 80% |
| Estimated percentage of unvaccinated babies who will have a lifelong Hepatitis B infection if infected | Over 90% |
| Estimated percentage of unvaccinated young children who will have a lifelong Hepatitis B infection if infected | 50% |
Explore related products
What You'll Learn
- The hepatitis B vaccine was licensed in 1981
- The vaccine was initially only recommended for high-risk groups
- Since 1991, all infants and young children have been recommended to receive the vaccine
- The World Health Organization recommends all infants receive the vaccine
- The vaccine is given as a series of 3 shots
The hepatitis B vaccine was licensed in 1981
The hepatitis B vaccine was first licensed in 1981. It was a "sophisticated plasma-derived hepatitis B vaccine" that was approved for use in high-risk groups. These groups included infants whose mothers were hepatitis B surface antigen positive, healthcare workers, intravenous drug users, homosexual men, and people with multiple sexual partners.
The vaccine was first developed by microbiologist Irving Millman, who also helped create a blood test for the hepatitis B virus. Blood banks began using the test in 1971 to screen blood donations, reducing the risk of hepatitis B infections from blood transfusions by 25%. In 1975, four years after the discovery of the virus, Dr. Millman developed the first hepatitis B vaccine, which was a heat-treated form of the virus.
The 1981 vaccine was an "inactivated" type that used blood from hepatitis B virus-infected donors. The blood was then subjected to multiple steps to inactivate the viral particles, including formaldehyde and heat treatment. Merck Pharmaceuticals manufactured this plasma vaccine as "Heptavax," the first commercial hepatitis B vaccine.
In 1986, the blood-derived hepatitis B vaccine was withdrawn from the market and replaced by Maurice Hilleman's improved recombinant hepatitis B vaccine, approved by the FDA. This new vaccine was the first human vaccine produced by recombinant DNA methods. It was based on a hepatitis B surface antigen (HBsAg) gene inserted into yeast cells, eliminating any concerns associated with human blood products.
Since its initial licensing, the hepatitis B vaccine has been recommended for various groups, including infants and adults. In 1991, the recommendation was made to immunize all infants, leading to the virtual elimination of hepatitis B disease in children under 18 years of age in the United States. More recently, in 2022, the license was expanded to include all adults up to 59 years of age who had not been previously vaccinated.
The hepatitis B vaccine is significant as it is the first anti-cancer vaccine, as it helps prevent liver cancer. Chronic hepatitis B and C cause 80% of all liver cancer cases, making vaccination an essential tool in cancer prevention.
Hep A Vaccine: When Was It Introduced?
You may want to see also
Explore related products
The vaccine was initially only recommended for high-risk groups
The hepatitis B vaccine was first licensed in 1981 but was initially only recommended for high-risk groups. This included infants born to mothers with hepatitis B, healthcare workers, intravenous drug users, homosexual men, and people with multiple sexual partners. However, this approach did not effectively stop the transmission of the hepatitis B virus. As a result, in 1991, the recommendation was changed to immunize all infants, and hepatitis B disease was virtually eliminated in children under 18 in the United States.
Over time, the recommended age groups for the hepatitis B vaccine have expanded. In 2018, the license was expanded to include people up to 45 years of age. In 2022, recommendations were updated to include all adults up to 59 years of age who had not been previously vaccinated. As of 2025, the CDC recommends hepatitis B vaccination for all newborns, children up to 18, adults 19-59 years old, and adults 60 and older who are at high risk of infection.
The hepatitis A vaccine, on the other hand, was first licensed in 1995. While it is recommended for all children and adolescents 2-18 years old who have not previously received it, it is particularly prioritized for those at higher risk of hepatitis A. This includes international travelers, men who have sex with men, people who use or inject drugs, people with certain jobs, people in close contact with an international adoptee, and people experiencing homelessness.
While the hepatitis B vaccine is generally given as a series of two or three shots, the hepatitis A vaccine requires two or three shots for full protection, depending on the specific vaccine brand. Both vaccines are safe and highly effective, even for those with compromised immune systems.
MMR Vaccine: Am I Immune Now?
You may want to see also
Explore related products
Since 1991, all infants and young children have been recommended to receive the vaccine
Hepatitis B is a liver infection caused by the hepatitis B virus. People who get infected can show no symptoms, or they may experience a mild illness that feels like the flu. In some cases, symptoms can be more severe, including fever, nausea, vomiting, and jaundice lasting for a few weeks. The hepatitis B vaccine (HepB) contains a killed (inactivated) virus, so it cannot cause hepatitis.
Since 1991, all infants and young children have been recommended to receive the hepatitis B vaccine. This change in recommendation was the result of failed attempts to control hepatitis B transmission by only immunizing high-risk groups, such as healthcare workers, intravenous drug users, and homosexual men. The disease was difficult to control because it can be transmitted by casual contact, and many chronically infected people are unaware of their infection.
The best time for newborns to receive the first dose of the hepatitis B vaccine is right after birth. This ensures that the child will be protected as quickly as possible. If a newborn's mother carries the hepatitis B virus, the baby must get the vaccine within 12 hours after birth, along with another shot of hepatitis B immune globulin (HBIG) for immediate protection. If the mother does not have the virus, the baby can receive the vaccine within 24 hours after birth or when discharged from the hospital.
The hepatitis B vaccine is typically given as a series of three shots. The vaccine usually creates long-term immunity, protecting children beyond childhood and into their adult years. Receiving the vaccine helps prevent severe liver disease, including cirrhosis and liver cancer, which can develop if infected with the hepatitis B virus.
Vaccines: Bloodstream Injections or Not?
You may want to see also
Explore related products
The World Health Organization recommends all infants receive the vaccine
The World Health Organization (WHO) recommends that all infants receive the hepatitis B vaccine within 24 hours of birth. This is known as the "birth dose" and is the first of three doses of the vaccine, with the others being administered at one month and six months of age. Completing the hepatitis B vaccine series as early as possible is essential to ensuring protection against hepatitis B, hepatitis delta, and lowering the lifetime risk of liver cancer.
The hepatitis B vaccine is considered one of the safest and most effective vaccines ever made, with more than one billion doses given worldwide. Numerous studies have been conducted by the WHO, the U.S. Centers for Disease Control and Prevention, and various medical societies, concluding that the vaccine is safe for infants and does not cause sudden infant deaths (SIDs), autism, multiple sclerosis, or other neurological disorders. Common side effects may include soreness, swelling, and redness at the injection site, and in extremely rare cases, a severe allergic reaction called anaphylaxis.
The birth dose is especially crucial for infants born to mothers with hepatitis B, as they are at a higher risk of infection. These infants must receive accurate doses of the hepatitis B vaccine and hepatitis B immune globulin immediately after birth in the delivery room or within the first 12-24 hours of life to ensure complete protection. Testing of all pregnant women for hepatitis B is a global recommendation to identify and protect these high-risk infants.
The recommendation for universal infant hepatitis B vaccination is a result of the failed attempts to control hepatitis B transmission by only immunizing high-risk groups in the early 1980s. The disease can be transmitted through casual contact, and many chronically infected people are unaware of their infection. Therefore, starting in 1991, the strategy was changed to vaccinate all infants and young children, leading to the virtual elimination of hepatitis B disease in children under 18 years of age in the United States.
The hepatitis B vaccine is also recommended for children up to 18 years of age and adults, especially those at high risk for infection due to their jobs, lifestyle, living situations, country of birth, or underlying medical conditions such as diabetes. It is important to note that the vaccine brand name, manufacturer, and schedule may vary depending on the country's national immunization program.
Booster Shots: Same Vaccine, Different Impact
You may want to see also
Explore related products
The vaccine is given as a series of 3 shots
The hepatitis B vaccine was first licensed in 1981 and initially recommended for high-risk groups, including infants born to hepatitis B-positive mothers. In 1991, health authorities began recommending the vaccine for all infants and young children, marking a shift in immunization strategy. This decision was made due to the recognition that around one-third of patients with acute hepatitis B did not belong to identifiable risk groups, making it challenging to control the disease's spread.
The hepatitis B vaccine is typically administered as a series of three shots, with the first shot ideally given within 12-24 hours of birth for infants born to hepatitis B-positive mothers. The subsequent two shots are usually given one month and six months after the initial dose. This vaccination schedule ensures maximum long-term protection against hepatitis B.
In certain cases, a newborn may require four doses of the hepatitis B vaccine. If a baby is born prematurely or has a low birth weight of less than 2000 grams (4 pounds, 7 ounces), they will receive the standard three doses starting at one month of age, along with an additional shot of hepatitis B immune globulin (HBIG) immediately after birth to provide immediate protection.
While the hepatitis B vaccine is primarily known for its monovalent form, combination vaccines such as the pentavalent and hexavalent vaccines are also available. These combination vaccines protect against multiple diseases, including hepatitis B, and are typically given starting at six weeks of age. However, for infants born to mothers with hepatitis B, the monovalent vaccine at birth is crucial to preventing vertical transmission of the virus.
The hepatitis B vaccine has been instrumental in reducing the incidence of hepatitis B infections in the United States, and it is now virtually eliminated in children under 18 years of age. The World Health Organization (WHO) recommends this vaccine for all infants worldwide, and it is often given in combination with other vaccines to reduce the overall number of shots a child receives.
Can Restaurants Legally Ask for Vaccination Proof?
You may want to see also
Frequently asked questions
The hepatitis B vaccine was first licensed in 1981 and recommended for high-risk groups. The first hepatitis B viral vaccines were developed by Merck and the Pasteur Institute and licensed in July 1983. Therefore, children born in 1984 may have received the hepatitis vaccine if they were considered high-risk.
High-risk groups included infants whose mothers were hepatitis B surface antigen-positive, healthcare workers, intravenous drug users, homosexual men, and people with multiple sexual partners.
In 1991, all infants and young children were recommended to receive the hepatitis B vaccine. This strategy has virtually eliminated hepatitis B infections in children under 18 in the US.
The World Health Organization (WHO) recommends that all infants receive the hepatitis B vaccine, ideally within 12-24 hours of birth, especially if their mothers are hepatitis B positive.
The hepatitis B vaccine is generally given as a three-dose series on a 0, 1, and 6-month schedule. The first shot is usually given at 6 weeks if the baby is born healthy and to a mother without hepatitis B.
